Banner

STUDY OF IRON STATUS PARAMETERS AND SERUM ALUMINUM LEVEL IN PATIENTS WITH CHRONIC RENAL FAILURE .EFFECT OF RECOMBINANT HUMAN ERYTHROPOIETN IN AND OTHER MODALITIES OF TREATMENT

BenhaM.J. • 1997
Back
Publication Information
Authors InasEl-ShaarawyMD.MohamedShawkyMD*,SoberAbdEl-RahmanMD,MohamedEl-HendyMDandSherifNigmMD*
Keywords Not Available
Journal BenhaM.J.
Publisher Not Available
Volume Vol. 14N02May1997
Issue Not Available
Pages 347-361
publication.type International
Paper Link Not Available
Supplementary Materials Not Available
Abstract
Thisstudywasconductedonfifiyuremicpatientsunderregularhaemodialysisand10healthycontrolsubjectsinordertostudytheparametersofironstatusandserumaluminuminthesepatients,andtoellucidatetheefiectofdifferentmodalitiesoftreatmentontheanemia,iron
statusparametersandserumaluminum,
Theuremicpatientswereclassifiedintofivegroups,eachincluded10 i
patients:groupIpatientsdidn'treceivetreatment,group11patientswas
givenTHLLEPO.groupIIIpatientswasgivenoraliron,groupIVpatientsreceivedcorrdvinedEPOandiron,whereasgroupVpatientsreceiveddesferroxamine.Thedurationoftreatmentwas6months.Thefollowinginvestigations, were performed before and after treatment: complete
bloodpicture,bloodurea,serumcreatinine,serumferritin,serumiron,total
ironbindingcapacity,ironbindingsaturation,serumaluminumandbone E
marrow(B.M)biopsy.
Ourstudyshowedthatanemiawasauniversalfindinginalluremic
patients60%hadmicrocytichypochromicand40%hadnormocyticnormochromicanemia.
SerumFe,TIBC,IBSandBMironstorageweresignificantlylowin
uremicpatients,whereasserumferritinandserumaluminumlevelswere
significantlyhighinthesepatients.